A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 547,400 shares of ORGO stock, worth $1.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
547,400
Previous 616,600 11.22%
Holding current value
$1.67 Million
Previous $1.73 Million 9.33%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.42 - $3.24 $167,464 - $224,208
-69,200 Reduced 11.22%
547,400 $1.57 Million
Q2 2024

Aug 14, 2024

SELL
$2.28 - $3.03 $450,983 - $599,334
-197,800 Reduced 24.29%
616,600 $1.73 Million
Q1 2024

May 15, 2024

SELL
$2.61 - $4.49 $165,735 - $285,115
-63,500 Reduced 7.23%
814,400 $2.31 Million
Q4 2023

Feb 14, 2024

SELL
$1.97 - $4.21 $205,471 - $439,103
-104,300 Reduced 10.62%
877,900 $3.59 Million
Q3 2023

Nov 14, 2023

SELL
$2.34 - $4.43 $148,122 - $280,419
-63,300 Reduced 6.05%
982,200 $3.12 Million
Q2 2023

Aug 14, 2023

SELL
$1.9 - $4.3 $75,050 - $169,850
-39,500 Reduced 3.64%
1,045,500 $3.47 Million
Q1 2023

May 15, 2023

BUY
$1.89 - $2.93 $419,769 - $650,753
222,100 Added 25.74%
1,085,000 $2.31 Million
Q4 2022

Feb 14, 2023

SELL
$2.48 - $3.43 $1.04 Million - $1.44 Million
-420,800 Reduced 32.78%
862,900 $2.32 Million
Q3 2022

Nov 14, 2022

BUY
$3.14 - $6.43 $1.14 Million - $2.33 Million
361,800 Added 39.25%
1,283,700 $4.16 Million
Q2 2022

Aug 15, 2022

BUY
$4.74 - $8.15 $343,650 - $590,875
72,500 Added 8.54%
921,900 $4.5 Million
Q1 2022

May 16, 2022

SELL
$6.47 - $9.57 $940,738 - $1.39 Million
-145,400 Reduced 14.62%
849,400 $6.47 Million
Q4 2021

Feb 14, 2022

BUY
$9.02 - $13.5 $602,536 - $901,800
66,800 Added 7.2%
994,800 $9.19 Million
Q3 2021

Nov 15, 2021

BUY
$13.71 - $17.18 $2.86 Million - $3.59 Million
208,800 Added 29.03%
928,000 $13.2 Million
Q2 2021

Aug 16, 2021

BUY
$14.92 - $23.23 $6.06 Million - $9.44 Million
406,200 Added 129.78%
719,200 $12 Million
Q1 2021

May 17, 2021

BUY
$7.33 - $21.06 $1.86 Million - $5.36 Million
254,300 Added 433.22%
313,000 $5.7 Million
Q4 2020

Feb 16, 2021

BUY
$3.63 - $7.53 $213,081 - $442,011
58,700 New
58,700 $442,000
Q3 2020

Nov 16, 2020

SELL
$3.29 - $4.58 $174,041 - $242,282
-52,900 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$2.86 - $4.61 $10,010 - $16,135
-3,500 Reduced 6.21%
52,900 $203,000
Q1 2020

May 15, 2020

BUY
$2.92 - $5.31 $68,620 - $124,784
23,500 Added 71.43%
56,400 $182,000
Q4 2019

Feb 14, 2020

BUY
$4.7 - $8.11 $154,630 - $266,819
32,900 New
32,900 $158,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $399M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.